Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker

Fig. 4

Analysis of the association between the expression levels of DTL and immunity in cancers. A Analysis of the association between the expression levels of DTL with six immune infiltrating cells, and results of most significant were displayed. B Analysis of the association between the expression levels of DTL and the tumor microenvironment score, concluding ImmuneScore, StromalScore, and ESTIMATEScore, and the most significant were displayed above. C Analysis of the association between the expression levels of DTL with 47 common ICP genes, *P < 0.05, **P < 0.01, ***P < 0.001. D Analysis of the expression of DTL and TMB by Spearman rank correlation analysis. E Analysis of the expression of DTL and MSI by Spearman rank correlation analysis. F We analyzed the correlation between DTL expression and five MMR genes: MLH1, MSH2, MSH6, PMS2, EPCAM, *P < 0.05, **P < 0.01, ***P < 0.001. G Analysis of relationship between the expression of DTL and whether response to immunotherapy in 298 cases of urothelial carcinoma (UC)

Back to article page